Influence of UPF genes on severity of SUP45 mutations
Eukaryotic cells possess a special mechanism for the degradation of mRNAs containing premature termination codons (PTCs), referred to as NMD (nonsense-mediated mRNA decay). The strength of this pathway depends on the recognition of the PTCs by translational machinery and the interaction of translati...
Saved in:
Published in | Molecular biology (New York) Vol. 46; no. 2; pp. 258 - 269 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
SP MAIK Nauka/Interperiodica
01.04.2012
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Eukaryotic cells possess a special mechanism for the degradation of mRNAs containing premature termination codons (PTCs), referred to as NMD (nonsense-mediated mRNA decay). The strength of this pathway depends on the recognition of the PTCs by translational machinery and the interaction of translation termination factors eRF1 and eRF3 with Upf1, Upf2 and Upf3 proteins in
Sachromyces cerevisiae
yeast. Previously, we have shown that the decrease of eRF1 protein amounts in
sup45
nonsense mutants leads to the impairment of NMD. Here we show that the deletion of
UPF1
or
UPF2
genes leads to an increase in the viability of
sup45
mutants, while the effect of
UPF3
gene deletion is allele-specific. Two-hybrid data have shown that amino acid residues 1–555 of Upf1 protein interact with eRF1. Any
UPF
gene deletion leads to allosupression of the
adel1-14
mutation without a change in eRF1 content. The Upf1 depletion does not influence the synthetic lethality of
sup45
mutations and the [
PSI
+
] prion. It is possible that the absence of Upf1 (or its activator Upf2) leads to a more effective formation of the translation termination complex and consequently to the increased viability of the cells containing mutant termination factors. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0026-8933 1608-3245 |
DOI: | 10.1134/S0026893312010256 |